We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Sartorius and Bosch Announce Global Collaboration for Aseptic Filling Equipment for Drug Products

By LabMedica International staff writers
Posted on 02 Jul 2012
Sartorius Stedim Biotech (SSB; Aubagne, France), an international pharma and biotech supplier, and Bosch Packaging Technology (Waiblingen, Germany), one of the leading providers of process technology and packaging solutions for the pharmaceutical industry, announced a long-term global partnership agreement. More...
The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of drug products.

SSB will provide Bosch with preconfigured single-use filling transfer sets, consisting of bags, filters, tubing, and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, novel systems for aseptic filling, and exclusively market, distribute, and service these new filling systems under its own brand name.

With the new product line PreVAS (prevalidated, preassembled, presterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012, held in June 2012 in Frankfurt (Germany).

Joachim Brenner, responsible for Bosch’s pharma liquid product range worldwide and site manager of the plant Crailsheim, stated, “By integrating SSB’s single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support.”

Jean-Marc Cappia, vice president of marketing, fluid management technologies, at SSB, stated, “The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way.”

Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry worldwide to develop drugs safely and cost-effectively.

Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. The company’s manufacturing and R&D sites are in Europe, North America, and Asia, with a global network of sales companies. Its key manufacturing and R&D site is in Germany.

The Bosch division of Packaging Technology is a leading supplier in the field of processing and packaging technology. The company develops and produces solutions for the pharmaceutical, food, and confectionery industries.

Bosch Packaging Technology--Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems, and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill and finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation services.

Related Links:

Sartorius Stedim Biotech
Bosch Packaging Technology



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Nutating Mixer
Enduro MiniMix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.